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Abstract
Background: Endometrial cavity fluid (ECF) is a fluid accumulation within the endometrial cavity. The significance
of ECF remains unclear during the program of in vitro fertilization-embryo transfer (IVF-ET). The aim of the present
study was to investigate the associated factors to ECF, visualized through ultrasound at the day of oocyte retrieval,
and the relevant impact on the outcome of IVF-ET.
Methods: From the clinical data of 1557 infertility patients for IVF-ET program, 46 ECF patients were retrospectively
selected as the ECF group; and another 134 patients with a bilateral salpingectomy and without ECF, selected as
the control group. The demographics and the outcome of IVF-ET were compared between the two groups.
Results: The incidence of ECF was 2.95% (46/1557). Over half (28/46, 60.87%) of ECF patients had tubal infertility.
Only 12 Of 46 ECF patients (26.09%) had visible hydrosalpinx on ultrasonography before ovarian stimulation. The
cycle cancellation rate (4/46, 8.69%) of ECF group was not significantly higher than that of the control group (6/
134, 4.48%; P > 0.05). Reasons for cycle cancellation in both groups were all the high risk of ovarian
hyperstimulation syndrome (OHSS). No significant difference was found in clinical pregnancy rate between the
patients with their ECF <3.5 mm in the anterior-posterior diameter (APD) and the control group (35.48% versus
30.47%; P > 0.05). No clinical pregnancy was found among those patients with their ECF equal or higher 3.5 mm in
APD.
Conclusions: It was tubal infertility, not hydrosalpinx, which was related to the development of ECF. Excessive ECF
(equal or higher 3.5 mm in APD) at the day of oocyte retrieval would have a negative impact on the outcome of
IVF-ET.
Background
Endometrial cavity fluid (ECF) is a fluid accumulation
within the endometrial cavity. Although the importance
of endometrial thickness during in vitro fertilization
(IVF) cycles has been documented much, the signifi-
cance of ECF remains unclear [1-7]. ECF after ovarian
stimulation and before embryo transfer (ET) is not a
common complication in IVF, but excessive uterine
fluid is detrimental to embryo implantation [1,2]. It was
hypothesized that embryonal apposition may not occur
when a fluid layer is overlaying the endometrium. A few
studies involving low numbers of patients have been
reported on the development of ECF in patients under-
going assisted reproductive techniques [1-7], some of
them claimed that the development of ECF was related
to hydrosalpinx [3,6,8,9] and some others, not[5,7]. The
cycles with ECF were considered by most researchers to
have low implantation and pregnancy rates as well as a
high incidence of cycle cancellation [1,2,5].
In our clinical practices, we found many cases with
ECF had their babies successfully through their IVF pro-
gram. Is there a defining value of ECF, above which, the
negative impact of ECF on the outcome of IVF-ET is
great; and under which, the negative impact might be
little?
T h ea i mo ft h ep r e s e n ts t u d yw a st oi n v e s t i g a t et h e
associated factors to ECF, visualized through ultra-
sound at the day of oocyte retrieval, and the relevant
impact on the outcome of IVF-ET. In the present
study, a retrospective investigation in this aspect was
shown based on the clinical data of infertility patients
enrolled for the IVF program. ECF patients were
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anterior-posterior diameter (APD) between the ante-
rior and posterior endometrial linings in a sagittal view
o fu t e r i n ec a v i t ya tt h ed a yo fo o c y t er e t r i e v a l ;a n d
non-ECF ones selected as the control group. The
demographics and the outcome of IVF-ET were com-
pared between groups.
Methods
Patients
The study was approved by the Review Board of
Women’s Hospital, Zhejiang University School of Medi-
cine. The clinical data of 1557 cycles of infertility
patients that enrolled in our IVF program between
March 1, 2006 and February 28, 2007 was retrospec-
tively reviewed. 46 patients were selected as the ECF
group, in which there was a fluid accumulation equal or
higher1.0 mm in the anterior-posterior diameter (APD)
in the uterine cavity of each patient at the day of oocyte
retrieval; and another 134 ones with a bilateral salpin-
gectomy selected as the control group, in which no fluid
accumulation was detected in their uterine cavities at
the day of oocyte retrieval.
The cervical stenosis of each selected patient has been
eliminated by the uterine exploration routinely carried
out at the initiation of each IVF program. No other
causes recorded influencing fertility, such as endome-
triosis, leiomyoma, etc., were found in each of the
selected cases. Cycles that involved the use of frozen
embryos, donor oocytes, or assisted hatching were
excluded. All pregnancies were confirmed by the rising
serum b-HCG levels and the gestational sacs identified
by transvaginal sonographic examination.
IVF-ET procedures
All patients underwent pituitary desensitization followed
by controlled ovarian hyperstimulation. Briefly, GnRH-
agonist suppression in a standard long protocol by s.c.
injections of triptorelin acetate (Decapaptyl, Ferring,
Germany), 0.1 mg/day started on Day 21 of the prior
menstrual cycle. Ovarian stimulation was then initiated
with rFSH (Gonal-F; Serono, Aubonne, Switzerland)
and/or HMG (Pergonal®; Serono Menotropin Livzon).
Follicular growth was monitored by assay of estradiol
(E2) levels and ultrasonography. When at least two lead-
ing follicles reached to a diameter >16 mm, HCG (Preg-
nyl; Serono, Aubonne, Switzerland) was administered at
a dose of 5000-10000 IU. Oocytes were retrieved by
transvaginal ultrasound-guided follicular aspiration 34-
36 h after HCG injection. The infertility due to severe
male factors was treated with the intracytoplasmic
sperm injection, while standard IVF techniques were
used for others. All patients had at least one good-qual-
ity embryo for transfer on the second or third day after
oocyte retrieval. The embryos were evaluated by a scor-
ing system named cumulative embryos score which was
based on blastomere number and fragmentation pattern
[10]. The number of embryos transferred varied between
patients. All ETs were performed with an Edward-Wal-
lace catheter (k-OPSD-1635-ET, COOK, Queensland,
Australia) under ultrasound guidance. Luteal support
consisted of 50 mg progesterone in oil administered i.m.
daily in patients who had ET performed.
Ultrasonography examination of ECF
Sonographic examinations were performed using an
Ultramark® 9 HDI (Advanced Technology Laboratories,
Bothell, WA, USA) with a 5 MHz multi-frequency
transvaginal probe. The endometrium was scanned
sagittally along the mid-line axis of the uterus. Altera-
tions in the endometrial thickness and echogenic pat-
tern/structure were recorded respectively during
gonadotrophin administration, on the day of oocyte
retrieval and on the day of ET.
Fluid accumulation within the uterine cavity was
defined as an echolucent ring configuration distended
by a certain amount of fluid and detected by transvagi-
nal ultrasound. Here, APD, the maximal fluid diameter
between the anterior and posterior (A-P) endometrial
linings in a sagittal view of uterine cavity, was used to
assess the degree of fluid accumulation (Fig. 1). In cases
of fluid accumulation, the thickness of endometrium
was measured by subtracting the maximal fluid diameter
from the maximal distance between the opposing myo-
metrial/endometrial interfaces. The maximal fluid dia-
meter and the surrounding endometrial thickness were
used as indices for analysis.
The charts of all patients undergoing IVF treatment
were searched for the presence of fluid accumulation
inside the uterine cavity on the day of oocyte retrieval.
That fluid might have disappeared or persisted until the
end of the cycle, but never aspirated. The cases whose
fluids were detected only during the period of ovarian
stimulation were excluded.
Statistics
Continuous data were presented as the mean ± SEM.
Comparisons between groups were performed using the
Mann-Whitney U-test or Student’s t-test as appropriate.
The statistical test to analyze the reproductive outcomes
was done using chi-square analysis. A P-value less than
0.05 was considered statistically significant.
Results
From a total of 1557 cycles involving 1546 patients, ECF
was detected in 46 cycles of 46 different women, with
an incidence of 2.95% (46/1557). In all of these cases,
the endometrium had been evaluated as normal before
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tion was emerged at the time of oocyte retrieval, after
HCG administration. The range of ECF in APD was
from 1.0 mm ~10.0 mm.
Over half (28 out of 46 cycles, 60.87%) of the women
who showed ECF during IVF-ET cycles had tubal infer-
tility. Only 12 of the 46 ECF cases (26.09%) had visible
hydrosalpinx on ultrasonography before ovarian stimula-
tion. Among the other 18 cases of ECF women with
non-tubal infertility, nine had endometriosis as the
infertility cause for IVF, six the male infertility factors,
two the unexplained infertility and one the polycystic
ovarian syndrome (PCOS).
The demographic, clinical parameters and cycle out-
comes of patients of the ECF group and control group
are shown as Table 1. Both groups were comparable in
terms of background characteristics. No difference was
detected in implantation rate (12.62% versus 17.97%;
X
2 = 1.529, P > 0.05), clinical pregnancy rates (26.19%
versus 30.47%; X
2 = 0.279, P > 0.05) and the cycle can-
cellation rate (8.69% versus 4.48%; X
2 = 1.161, P > 0.05)
between the two groups. Reasons for cancellation of the
corresponding cycles in both groups were all the high
risk of ovarian hyperstimulation syndrome (OHSS).
In order to investigate the impact of ECF on clinical
outcome further, the level distribution of ECF in APD
of the 46 patients and their cycle outcomes was ana-
lyzed and the results were shown at Table 2. Majority
(97.83%) of ECF were distributed at APD 1.0 mm ~<
5.0 mm. No significant difference of ECF distribution
was found at that APD interval. However, significant dif-
ferences of implantation rate and clinical pregnancy rate
were found between the three ECF distribution groups
with their APD <3.5 mm (1.0 mm~, 2.0 mm~, and
3.0 mm~respectively) and the ECF distribution group
with its APD equal or higher3.5 mm ~< 5.0 mm (P <
0.05). In the present study, the clinical pregnancy could
be found in patients with their maximum ECF at APD
3.4 mm. No clinical pregnancy was found in the patients
with their ECF at APD equal or higher3.5 mm.
In order to illustrate the tendency of ECF level and
the relevant cycle outcomes, all 46 cases were divided
into two big subgroups by the APD of ECF as group-I:
1.0 mm < APD < 3.5 mm (n = 34) and group-II: APD
equal or higher3.5 mm (n = 12). The clinical data and
the cycle outcomes of the two big subgroups of ECF
patients were shown as Table 3. There were no signifi-
cant differences in patient characteristics between the
two big subgroups. One case was cancelled her ET in
the group-II because of the high risk of OHSS; while
there were three cases cancelled in the group-I for the
same reason. So the cancellation rates between the two
subgroups were similar (8.33% versus 8.88%, X
2 = 0.003,
P > 0.05). However, as mentioned above, the clinical
pregnancy rate of the group-II was significantly lower
than that of the group-I during the follow-up period
(0% versus 35.48%; X
2 = 5.288, P < 0.05). So was
the implantation rate (0% versus 17.81%; X
2 = 6.114,
P < 0.05).
Discussion
The present study showed that the presence of relatively
s m a l la m o u n to fE C F( A P D<3 . 5m m )a tt h ed a yo f
oocyte retrieval did not appear to negatively impact the
clinical pregnancy rate of IVF-ET program; while the
presence of excessive amount of ECF (APD equal or
Figure 1 Endometrial cavity fluid (ECF). Fluid accumulation in the uterine cavity detected by transvaginal ultrasound in a sagittal view (A–P
diameter 2.5 mm) in a patient on the day of oocyte retrieval.
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those described previously in some relevant studies
[1,4,5]. The researchers of those studies held that ECF
observed after HCG administration represents a differ-
ent clinical entity and that, if the ECF was generated
physiologically by the genital tract, like the ECF demon-
strated in those patients without hydrosalpinx or bilat-
eral tubal obstruction, the clinical pregnancy rate of the
involved ECF patient was not worse than that of those
patients without ECF and no influence of this kind of
ECF on embryo implantation was found.
The time of ECF development is important in the
impact of ECF on the IVF-ET outcome. Many studies
demonstrated that the ECF detected during ovarian sti-
mulation usually had a negative impact on the IVF-ET
outcome [1,5,7,9]. If ECF transiently developed after
receiving an HCG injection and disappeared by the day
of embryo transfer, the ECF did not impact the clinical
pregnancy rate [1,5]. In the present study, all ECFs
were firstly observed after HCG administration and at
the time of oocyte retrieval. As described in the above,
no obvious impact of ECF on the IVF-ET outcome was
Table 2 The ECF level in APD and the relevant cycle outcomes in the ECF patients
Cycle outcomes The ECF level in APD (mm) In total
1.0~ 2.0~ 3.0~ 3.5~ 5.0~10.0
Case number (%) 13/46
(28.26)
12/46
(26.09)
9/46
(19.57)
11/46
(23.91)
1/46
(2.17)
46/46
(100.0)
Cancellation rates (%) 1/13
(7.69)
1/12
(8.33)
1/9
(11.11)
1/11
(9.10)
0/1
(0.00)
4/46
(8.69)
Implantation rates (%) 6/30
(20.00)
4/24
(16.67)
3/19
(15.79)
0/28
(0.00)*
0/2
(0.00)
13/103
(12.62)
Clinical pregnancy rate/ET (%) 4/12
(33.33%)
4/11
(36.36)
3/8
(37.50%)
0/10
(0.00)*
0/1
(0.00)
11/42
(26.19)
ECF: endometrial cavity fluid; APD: the anterior–posterior diameter of endometrial cavity fluid.
*:Compared with the former 3 groups (APD 1.0 ~, 2.0 ~and 3.0 ~), X
2 > 3.841, P < 0.05.
Table 1 Patients’ demographics and cycle parameters
ECF Group
(n = 46)
Control Group
(n = 134)
p –value
(95% CI)
Age (years old) 31.5 ± 0.5 31.8 ± 0.1 >0.05
Duration of infertility (years) 5.4 ± 0.4 5.5 ± 0.1 >0.05
Baseline FSH (mIU/ml) 7.8 ± 1.2 7.6 ± 1.6 >0.05
Baseline LH (mIU/ml) 5.0 ± 1.5 5.1 ± 1.7 >0.05
E2 level on the day of HCG (pg/ml) 2188.6 ± 1546.9 2210.5 ± 1125.8 >0.05
Stimulation length (days) 10.3 ± 0.3 10.8 ± 0.1 >0.05
Number of oocytes retrieved 13.2 ± 5.9 13. 7 ± 5.5 >0.05
Endometrial thickness (HCG day) (mm) 11.0 ± 1.1 10.8 ± 2.3 >0.05
Number of fertilized oocytes 8.1 ± 4.3 8.8 ± 4.9 >0.05
Number embryos transferred 2.7 ± 0.7 2.5 ± 0.6 >0.05
Number of cleavage stage embryos 8.0 ± 3.8 8.5 ± 5.0 >0.05
CES
a of D3 56.4 ± 17.1 56.1 ± 16.3 >0.05
Grade I–II/all embryos transferred (%) 38/42
(90.47)
116/128
(90.63)
>0.05
(90.45~99.95%)
Cancellation rates (%) 4/46
(8.69)
6/134
(4.48)
>0.05
(21.53~34.67%)
Implantation rates (%) 13/103
(12.62)
46/256
(17.97)
>0.05
(19.43%~23.77%)
Clinical pregnancy/embryo transfer (%) 11/42
(26.19)
39/128
(30.47)
>0.05
(52.33%~67.07%)
Multiple pregnancy rates (%) 2/11
(18.18%)
7/39
(17.94%)
>0.05
(95.35%~100.0%)
Values are expressed as the mean ± SEM.
ECF Group: patients with endometrial cavity fluid accumulation (equal or higher1.0 mm); Control Group: patients with bilateral tubal resection and without
endometrial cavity fluid accumulation. a: CES means cumulative embryo score, defined, on the day of embryo transfer, by the multiplication of gradingo f
fragmentation pattern of each embryo with blastomere number of the embryo to produce a single score for each embryo, and, then, by the summation of all
single scores obtained from all the embryos transferred [10].
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3.5 mm).
The amount of ECF is also critical in the impact of ECF
on the IVF-ET outcome. Among the previous relevant
studies, to our knowledge, only one was conducted on
the effects of ECF amount on the outcome of IVF-ET.
The researchers of that study found that a large amount
of ECF (>3.0 mm in the largest diameter) usually devel-
oped after receiving HCG and that the large amount of
ECF was detrimental to embryo implantation [2]. In the
present studies, the large amount of ECF was defined as
equal or higher 3.5 mm in APD and the small amount of
ECF was < 3.5 mm in APD. Both large and small amount
of ECF could be found in the present study after HCG
injection. The ECF less than 3.5 mm in APD usually dis-
appeared by the time of ET; while the ECF more than 3.5
mm in APD usually persisted and enlarged until during
implantation period. The presence of small amount of
ECF (APD < 3.5 mm) at the day of oocyte retrieval did
not appear to negatively impact the clinical pregnancy
rate of IVF-ET program, when compared with that of the
control patients without ECF; while the presence of
excessive amount of ECF (APD equal or higher 3.5 mm)
would do. To our knowledge, the present study was the
first one to set up equal or higher 3.5 mm in APD of ECF
as the defining value of large of fluid, such that embryo
cryopreservation should be considered in patients.
Further studies are needed to be conducted to clarify
the real effect of ECF on the IVF-ET outcome and the
real mechanism for the development of ECF.
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